Rongsheng Zhao

9PUBLICATIONS
12CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 10, 2025
Push Forward Clinical Management of Hematological Toxicity due to Lenalidomide Overexposure: Model-Informed Precision Dosing for Chinese Population With Renal Insufficiency.

Yi Ma, Zaiwei Song, Hao Bing

|Jan 30, 2025
Correction: Immune checkpoint inhibitors-related thyroid dysfunction: influencing factor analysis, prediction model development, and management strategy proposal.

Xinya Li, Zaiwei Song, Yixuan Chen

|Nov 02, 2024
Immune checkpoint inhibitors-related thyroid dysfunction: influencing factor analysis, prediction model development, and management strategy proposal.

Xinya Li, Zaiwei Song, Yixuan Chen

|May 30, 2024
Therapeutic drug monitoring guidelines in oncology: what do we know and how to move forward? Insights from a systematic review.

Xinya Li, Zaiwei Song, Zhanmiao Yi

|Apr 29, 2024
Clinical characteristics and pharmacokinetics of PAXLOVID in COVID-19 patients with hematological tumor.

Wei Liu, Ping Yang, Ping Yang

|Mar 05, 2024
Acute kidney injury events in patients with diabetes using sodium glucose transporter 2 inhibitors: a meta-analysis of cohort studies.

Yanjing Shi, Shujie Dong, Yang Xu

Pageof 2

Frequent Collaborators

5 joint publications

Zaiwei Song

4 joint publications

Xinya Li

2 joint publications

Zhanmiao Yi

2 joint publications

Libo Zhao